药物联络助产士:解决围产期物质使用问题的创新
Nursing for women's health
|December 19, 2025
概括
苏格兰的专门助产士改善了对使用物质的孕妇的护理. 他们的专业,跨学科的方法提高了母亲和婴儿的结果,为美国提供了一个模型.
科学领域:
- 围产期护理 围产期护理
- 公共卫生 公共卫生
- 助产士实践中的助产士实践
背景情况:
- 在20世纪90年代,孕妇中海洛因使用的增加促使人们需要专业护理.
- 传统的方法不足以解决围产期物质使用的复杂性.
- "怀孕中的脆弱"计划是为了解决这些护理缺口而出现的.
研究的目的:
- 探索苏格兰的创新助产实践,以支持使用物质的孕妇.
- 检查周产期物质使用护理的历史背景和当前趋势.
- 确定在美国复制成功的苏格兰模式的机会.
主要方法:
- 对围产期物质使用的历史和当前趋势的评论和分析.
- 检查"怀孕中的脆弱"计划的发展和影响.
- 专业助产士实施的跨学科实践的审查.
主要成果:
- "怀孕中的脆弱"计划显著改善了对脆弱孕妇群体的护理.
- 专注的助产士领导力推动了跨学科围产期物质使用护理的演变.
- 这些做法已经导致改善了母亲和婴儿的结果.
结论:
- 苏格兰的专门助产士实践为支持使用物质的孕妇提供了一个成功的模式.
- 跨学科的合作是提高围产期物质使用护理的关键.
- 在美国复制这些创新实践可以改善弱势群体的结果.
相关概念视频
Combined Effects of Drugs: Synergism
6.4K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.4K
Prodrugs
4.1K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
4.1K
Birth Control Methods
5.6K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
5.6K
Drug Administration and Therapy Phases: Overview
2.0K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
2.0K
Modified-Release Drug Delivery Systems: Drug Release Characteristics
263
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
263
Intrauterine Drug Delivery Systems
169
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
169


